Home › Funds › TORNO CAPITAL, LLC › PLRX

TORNO CAPITAL, LLC position in PLRX

PLIANT THERAPEUTICS INC · Health Care

TORNO CAPITAL, LLC reported holding 351,445 shares of PLRX (PLIANT THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$401K, representing 0.02% of its reported portfolio and ranking #35 among its reported holdings. TORNO CAPITAL, LLC has disclosed PLRX holdings in 4 of the last 4 reported quarters, going back to Q3 2025.

Latest position (Q2 2026)351.44K sh
Reported value held$400.65K
Portfolio Weight0.02%
First reportedQ3 2025
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How TORNO CAPITAL, LLC's PLRX position evolved

TORNO CAPITAL, LLC first disclosed a stake in PLRX in Q3 2025 at 130,916 shares (US$194K). The position peaked in Q1 2026 at 350,000 shares, worth US$441K. Across 4 filings, TORNO CAPITAL, LLC increased the stake 2 time(s), trimmed it 0 time(s) and left it unchanged 1 time(s). The most recent filing (Q2 2026) shows 351,445 shares valued at US$401K. Notable position changes include a 144% increase in Q4 2025 (shares rose 3% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2025 130.92K $193.76K New
Q4 2025 320.00K $390.40K Add
Q1 2026 350.00K $441.00K Add
Q2 2026 351.44K $400.65K Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About PLRX and 13F data

PLRX (PLIANT THERAPEUTICS INC) is a Health Care company. 8 other funds we track also report a position in PLRX — the largest reported positions include TANG CAPITAL MANAGEMENT LLC (US$7.0M), Monaco Asset Management SAM (US$2.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding PLRX

All PLRX fund holders →

FAQ

How long has TORNO CAPITAL, LLC held PLRX?

TORNO CAPITAL, LLC has disclosed PLRX holdings in 4 of the last 4 reported quarters, going back to Q3 2025.

What is TORNO CAPITAL, LLC's current position in PLRX?

As of Q2 2026, TORNO CAPITAL, LLC holds 351.44K shares of PLRX (PLIANT THERAPEUTICS INC), valued at $400.65K, representing 0.02% of its reported portfolio and ranking #35.

Has TORNO CAPITAL, LLC been buying or selling PLRX?

In the latest 13F filing (Q2 2026), TORNO CAPITAL, LLC held unchanged its position in PLRX. The position peaked in Q1 2026 at 350.00K shares.

Which other funds hold PLRX?

Other major institutional holders of PLRX include TANG CAPITAL MANAGEMENT LLC, Monaco Asset Management SAM, among 8 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.